Camelot Portfolios’s Colgate-Palmolive CL Stock Holding History

Camelot Portfolios’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400	Closed	-$31.6K	–	258
2025 Q4	$31.6K	Buy	+400	New	+$31.4K	0.02%	342
2024 Q3	–	Sell	-673	Closed	-$65.3K	–	217
2024 Q2	$65.3K	Buy	+673	New	+$62.1K	0.04%	280
2015 Q2	–	Sell	-50,000	Closed	-$50K	–	174
2015 Q1	$50K	Buy	+50,000	New	+$3.46M	0.03%	166

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Camelot Portfolios's CL Position: Q1 2026 in Review

Camelot Portfolios sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 400 shares — an estimated $31.6K sold.

Camelot Portfolios first reported a position in CL in Q1 2015 and held it in 3 quarters. The position peaked at $65.3K in Q2 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Camelot Portfolios reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Camelot Portfolios sold 400 Colgate-Palmolive shares in Q1 2026, an estimated $31.6K.
Camelot Portfolios first reported a position in Colgate-Palmolive in Q1 2015 and held it in 3 quarters.
Camelot Portfolios's Colgate-Palmolive position peaked at $65.3K in Q2 2024.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.